Form 4: Organogenesis Director Duraibabu Prathyusha Reports Stock Grant and Holdings

Director Duraibabu Prathyusha reports receiving a grant of restricted stock units and changes in beneficial ownership of Organogenesis Holdings Inc. stock.

Summary

• On February 19, 2025, Duraibabu Prathyusha, a director of Organogenesis Holdings Inc., reported a transaction involving the company's Class A Common Stock.
• Prathyusha acquired 49,575 shares of Class A Common Stock through a grant of restricted stock units (RSUs) at a price of $0.
• These RSUs vest in full on February 15, 2026, and each RSU represents the right to receive one share of Organogenesis Class A common stock.
• Following the reported transaction, Prathyusha directly owns 198,219 shares of Organogenesis Class A Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns director interests with shareholders.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.
• The vesting schedule of the RSUs (full vesting on February 15, 2026) encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting date of the RSUs.

Industry Context

This filing is a routine disclosure related to equity compensation for a company director, which is a common practice in publicly traded companies to incentivize and retain key personnel.

Stakeholder Impact

• The grant of RSUs could have a slightly positive impact on shareholders by aligning the director's interests with the company's long-term success.

Key Dates

Keywords

Organogenesis Holdings Inc., ORGO, Duraibabu Prathyusha, Director, Form 4, Beneficial Ownership, Restricted Stock Units, RSUs, Class A Common Stock, Equity Incentive Plan